Australia approves new drug to slow Alzheimer’s progression
Alzheimer’s disease, the most common form of dementia, affects nearly 600,000 Australians. But there is renewed hope, with Australia’s Therapeutic Goods Administration approving a new medication that could offer relief to those living with the condition. Researchers say the drug represents a major breakthrough in the ongoing quest for more effective treatments.
SBS Hindi · SBS Audio
May 26, 20255m 39sFULL
Audio is streamed directly from the publisher (sbs-podcast.streamguys1.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Alzheimer’s disease, the most common form of dementia, affects nearly 600,000 Australians. But there is renewed hope, with Australia’s Therapeutic Goods Administration approving a new medication that could offer relief to those living with the condition. Researchers say the drug represents a major breakthrough in the ongoing quest for more effective treatments.